美国 · SEC FORM 4
Kiniksa Pharmaceuticals International, plc
KNSA · Nasdaq · CIK 0001730430 · Healthcare · Drug Manufacturers—Specialty & Generic
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
61 同一窗口内观察到的 Form 4 交易行
12 sales · 49 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
Showing the six most active owners; 6 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot.—
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 3,778,657
- 上期报告
- 3,876,769
- 日均成交量
- 589,057
- 回补天数
- 6.4
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
本地 Form 4 历史中没有合资格的代码 P 股票买入。
Form 4 申报证据
154 transaction lines in the latest 365-day window; 706 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-03 | Megna Michael R | 卖出 (S) | Class A Ordinary Share | 4,600 | USD 80.30 | USD 369,380 | SEC 申报 ↗ |
| 2026-09-01 | Ragosa Mark | 期权行权／转换 (M) | Class A Ordinary Share | 9,104 | USD — | USD — | SEC 申报 ↗ |
| 2026-09-01 | Ragosa Mark | 代扣税 (F) | Class A Ordinary Share | 4,404 | USD 79.28 | USD 349,149 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-03 | Megna Michael R | 卖出 (S) | Class A Ordinary Share | 4,600 | USD 80.30 | USD 369,380 | SEC 申报 ↗ |
| 2026-09-01 | Ragosa Mark | 期权行权／转换 (M) | Class A Ordinary Share | 9,104 | USD — | USD — | SEC 申报 ↗ |
| 2026-09-01 | Ragosa Mark | 代扣税 (F) | Class A Ordinary Share | 4,404 | USD 79.28 | USD 349,149 | SEC 申报 ↗ |
| 2026-09-01 | Patel Sanj K | 期权行权／转换 (M) | Class A Ordinary Share | 31,318 | USD — | USD — | SEC 申报 ↗ |
| 2026-09-01 | Patel Sanj K | 期权行权／转换 (M) | Class A Ordinary Share | 31,318 | USD — | USD — | SEC 申报 ↗ |
| 2026-09-01 | Patel Sanj K | 代扣税 (F) | Class A Ordinary Share | 15,144 | USD 79.28 | USD 1,200,616 | SEC 申报 ↗ |
| 2026-09-01 | Patel Sanj K | 代扣税 (F) | Class A Ordinary Share | 15,144 | USD 79.28 | USD 1,200,616 | SEC 申报 ↗ |
| 2026-09-01 | Paolini John F. | 期权行权／转换 (M) | Class A Ordinary Share | 8,328 | USD — | USD — | SEC 申报 ↗ |
| 2026-09-01 | Paolini John F. | 代扣税 (F) | Class A Ordinary Share | 4,029 | USD 79.28 | USD 319,419 | SEC 申报 ↗ |
| 2026-09-01 | Moat Ross | 期权行权／转换 (M) | Class A Ordinary Share | 8,285 | USD — | USD — | SEC 申报 ↗ |
| 2026-09-01 | Moat Ross | 代扣税 (F) | Class A Ordinary Share | 4,007 | USD 79.28 | USD 317,675 | SEC 申报 ↗ |
| 2026-09-01 | Megna Michael R | 期权行权／转换 (M) | Class A Ordinary Share | 11,496 | USD — | USD — | SEC 申报 ↗ |
| 2026-09-01 | Megna Michael R | 代扣税 (F) | Class A Ordinary Share | 5,531 | USD 79.28 | USD 438,498 | SEC 申报 ↗ |
| 2026-08-19 | Quart Barry D | 赠与 (G) | Class A Ordinary Share | 2,600 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-01 | Levy Richard S | 期权行权／转换 (M) | Class A Ordinary Share | 403 | USD — | USD — | SEC 申报 ↗ |
| 2026-07-29 | Cole G Bradley | 卖出 (S) | Class A Ordinary Share | 3,673 | USD 81.43 | USD 299,092 | SEC 申报 ↗ |
| 2026-07-29 | Cole G Bradley | 赠与 (G) | Class A Ordinary Share | 4,500 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-15 | Megna Michael R | 奖励／授予 (A) | Class A Ordinary Share | 279 | USD 33.50 | USD 9,346 | SEC 申报 ↗ |
| 2026-06-01 | Patel Sanj K | C (C) | Class A Ordinary Share | 900,000 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-29 | Quart Barry D | 期权行权／转换 (M) | Class A Ordinary Share | 2,799 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-29 | Popovits Kimberly J | 期权行权／转换 (M) | Class A Ordinary Share | 2,799 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-29 | McCain Tracey L | 期权行权／转换 (M) | Class A Ordinary Share | 2,799 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-29 | Malley Thomas | 期权行权／转换 (M) | Class A Ordinary Shares | 2,799 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-29 | Levy Richard S | 期权行权／转换 (M) | Class A Ordinary Share | 2,799 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-29 | Cole G Bradley | 期权行权／转换 (M) | Class A Ordinary Share | 2,799 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-29 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | 奖励／授予 (A) | Class A Ordinary Shares | 6,078 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-01 | Paolini John F. | 卖出 (S) | Class A Ordinary Share | 58,424 | USD 53.71 | USD 3,137,823 | SEC 申报 ↗ |
| 2026-05-01 | Paolini John F. | 期权行权／转换 (M) | Class A Ordinary Share | 58,424 | USD 10.36 | USD 605,273 | SEC 申报 ↗ |
| 2026-05-01 | Patel Sanj K | 卖出 (S) | Class A Ordinary Share | 48,565 | USD 54.02 | USD 2,623,481 | SEC 申报 ↗ |
| 2026-05-01 | Patel Sanj K | 期权行权／转换 (M) | Class A Ordinary Share | 48,565 | USD 30.93 | USD 1,502,115 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | KNSA |
| CIK | 0001730430 |
| 行业 | Healthcare |
| 细分行业 | Drug Manufacturers—Specialty & Generic Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 706 transaction lines from 2020-02-13 to 2026-09-03 0 P purchase lines · 177 S sale lines · 529 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.